Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
4.
Chemosphere ; 198: 59-67, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29421761

RESUMEN

Inappropriate treatments for the effluents from semiconductor plants might cause the releases and wide distributions of selenium (Se) into the ecosystems. In this study, Al/Si and Fe/Si coprecipitates were selected as model adsorbents as they often formed during the wastewater coagulation process, and the removal efficiency of selenite (SeO3) and selenate (SeO4) onto the coprecipitates were systematically examined. The removal efficiency of SeO3 and SeO4 was highly related to surface properties of Al/Si and Fe/Si coprecipitates. The surface-attached Al shell of Al/Si coprecipitates shielded a portion of negative charges from the core SiO2, resulting in a higher point of zero charge than that of Fe/Si coprecipitates. Thus, adsorption of SeO3/SeO4 was favorable on the Al/Si coprecipitates. Adsorptions of both SeO3 and SeO4 on Al/Si coprecipitates were exothermic reactions. On Fe/Si coprecipitates, while SeO3 adsorption also showed the exothermic behavior, SeO4 adsorption occurred as an endothermic reaction. The kinetic adsorption data of SeO3/SeO4 on Al/Si and Fe/Si coprecipitates were described well by the pseudo-second-order kinetic model. SeO4 and SeO3 adsorption on Fe/Si or Al/Si were greatly inhibited by the strong PO4 ligand, whereas the weak ligand such as SO4 only significantly affected SeO4 adsorption. The weakest complex between SeO4 and Al was implied by the essentially SeO4 desorption as SeO4/PO4 molar ratios decreased from 0.5 to 0.2. These results were further confirmed by the less SeO4 desorption (41%) from Fe/Si coprecipitates than that from Al/Si coprecipitates (78%) while PO4 was added sequentially.


Asunto(s)
Residuos Industriales/prevención & control , Selenio/química , Semiconductores , Adsorción , Aluminio/química , Precipitación Química , Residuos Industriales/análisis , Hierro/química , Cinética , Ácido Selénico/aislamiento & purificación , Ácido Selenioso/aislamiento & purificación , Propiedades de Superficie , Contaminantes Químicos del Agua/aislamiento & purificación
5.
Artículo en Inglés | MEDLINE | ID: mdl-22454666

RESUMEN

Maclura tinctoria (L.) D. Don ex Steud. has one of the highest qualities among the coefficients for Brazilian woods (up to 9.6) and resistance rates equivalent to Indian teak (Tectona grandis). In this study, the macromolecular constituents and total phenols compounds as well as the antioxidant and antibacterial activities of this wood were evaluated. Total phenols and proanthocyanidin levels were higher in wood when compared with bark levels. The antioxidant activity of wood extracts (IC(50) = 18.7 µg/mL) was more effective than that of bark extracts (IC(50) = 20.9 µg/mL). Wood and bark extracts revealed a high potential for inhibition of aerobic and anaerobic bacteria. The bark extracts were the most active (MIC from 20 to 60 µg/mL). Both antioxidant activity and high potential for bacteria inhibition turn these extracts promising for drug formulations, especially as antibacterial agent.

6.
Br J Pharmacol ; 149(6): 761-74, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17016515

RESUMEN

BACKGROUND AND PURPOSE: To further assess the clinical potential of the blockade of metabotropic glutamate receptors (mGluR1) for the treatment of pain. EXPERIMENTAL APPROACH: We characterized the effects of A-841720, a novel, potent and non-competitive mGluR1 antagonist in models of pain and of motor and cognitive function. KEY RESULTS: At recombinant human and native rat mGluR1 receptors, A-841720 inhibited agonist-induced calcium mobilization, with IC50 values of 10.7+/-3.9 and 1.0 +/- 0.2 nM, respectively, while showing selectivity over other mGluR receptors, in addition to other neurotransmitter receptors, ion channels, and transporters. Intraperitoneal injection of A-841720 potently reduced complete Freund's adjuvant-induced inflammatory pain (ED50 = 23 micromol kg(-1)) and monoiodoacetate-induced joint pain (ED50 = 43 micromol kg(-1)). A-841720 also decreased mechanical allodynia observed in both the sciatic nerve chronic constriction injury and L5-L6 spinal nerve ligation (SNL) models of neuropathic pain (ED50 = 28 and 27 micromol kg(-1), respectively). Electrophysiological studies demonstrated that systemic administration of A-841720 in SNL animals significantly reduced evoked firing in spinal wide dynamic range neurons. Significant motor side effects were observed at analgesic doses and A-841720 also impaired cognitive function in the Y-maze and the Water Maze tests. CONCLUSIONS AND IMPLICATIONS: The analgesic effects of a selective mGluR1 receptor antagonist are associated with motor and cognitive side effects. The lack of separation between efficacy and side effects in pre-clinical models indicates that mGluR1 antagonism may not provide an adequate therapeutic window for the development of such antagonists as novel analgesic agents in humans.


Asunto(s)
Analgesia , Cognición/efectos de los fármacos , Antagonistas de Aminoácidos Excitadores/farmacología , Compuestos Heterocíclicos con 3 Anillos/farmacología , Actividad Motora/efectos de los fármacos , Receptores de Glutamato Metabotrópico/antagonistas & inhibidores , Animales , Células Cultivadas , Fluorescencia , Humanos , Masculino , Ratas , Ratas Sprague-Dawley
7.
Int J Tuberc Lung Dis ; 9(9): 1006-12, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16158893

RESUMEN

SETTING: Tainan city, Tainan county and 13 townships of Kaohsiung county, Southern Taiwan. OBJECTIVE: To measure delays in the diagnosis and treatment of sputum-positive tuberculosis (TB) and to determine factors associated with delays in seeking health care (patient delay) and in starting anti-tuberculosis treatment (health system delay). DESIGN: A population-based patient interview study. RESULTS: Median patient delay was 7 days (range 0-730). Median health system delay was 23 days (range 0-489), 13 for smear-positive patients and 37 for smear-negative patients (P < 0.005). Median total delay was 44 days (range 0-730). Age <65 years was associated with longer patient delay. Negative smear, absence of haemoptysis, not having a chest radiograph at the first medical consultation and visiting clinics for first consultation were associated with a longer health system delay. Age <65 years, negative smear and cough as the only presenting symptom were associated with longer total delay. CONCLUSION: Patient delay was substantially shorter than health system delay. To reduce health system delay, clinics need to be involved and the referral mechanism must be strengthened. Physicians should maintain high alert for TB and perform prompt sputum smear examinations.


Asunto(s)
Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/terapia , Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Análisis Multivariante , Programas Nacionales de Salud , Modelos de Riesgos Proporcionales , Factores de Riesgo , Taiwán/epidemiología , Tuberculosis Pulmonar/epidemiología
8.
J Clin Endocrinol Metab ; 90(5): 2810-5, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15728200

RESUMEN

Compared with normal women, adults with polycystic ovarian syndrome (PCOS) require higher progesterone (P) concentrations to inhibit GnRH (LH) pulse frequency, which contributes to persistently rapid GnRH pulses and elevated LH levels in PCOS. To explore the origin of this abnormality, we assessed hypothalamic sensitivity to P feedback in nine normal controls and 11 hyperandrogenemic (HA) adolescents. Subjects first underwent frequent blood sampling for 11 h to assess baseline LH pulse frequency. Thereafter, oral estradiol and micronized P were given for 7 d to achieve mean estradiol and P levels of 143 +/- 16 pg/ml (524 +/- 60 pmol/liter) and 7.8 +/- 0.7 ng/ml (24.9 +/- 2.3 nmol/liter), respectively. LH pulse frequency was then reassessed. On d 7, the slope of the percent reduction of LH pulses per 11 h as a function of the d 7 P concentration was less in the HA group compared with controls (P = 0.02) despite similar P levels. LH pulse frequency was suppressed in all NC (mean, 7.0 to 3.4 pulses/11 h), but was unchanged in six of the HA girls (mean, 8.3 to 7.5 pulses/11 h). In contrast, in the other five HA adolescents, P induced similar slowing of LH pulses to that seen in NC (mean, 10.0 to 5.0 pulses/11 h). Baseline free testosterone levels were similar in both HA groups; the only observed difference between these HA groups is that the P-suppressible subjects were all of Hispanic descent. These data suggest that hyperandrogenemia during adolescence is variably associated with decreased sensitivity to P, which may have a partially genetic basis.


Asunto(s)
Hormona Liberadora de Gonadotropina/metabolismo , Hiperandrogenismo/metabolismo , Hipotálamo/efectos de los fármacos , Progesterona/farmacología , Adolescente , Estradiol/farmacología , Femenino , Humanos , Hipotálamo/metabolismo , Hormona Luteinizante/metabolismo , Síndrome del Ovario Poliquístico/metabolismo
9.
J Clin Endocrinol Metab ; 88(9): 4077-9, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12970265

RESUMEN

One of the most important issues in women's health concerns the risks and benefits of estrogen replacement therapy. Continual uncertainty and lack of consensus regarding estrogen replacement therapy has driven many women to seek alternative sources of estrogen, including herbal remedies. We adapted a recombinant cell bioassay to measure estrogen bioactivity in herbs. We studied, in vitro, estrogen bioactivity in red clover, dong quai, black cohosh, soy, licorice, chaste tree berry, fo-ti, and hops. Soy, clover, licorice, and hops have a large amount of measurable estrogen bioactivity, as suspected, based on previous reports using other methods. We discovered surprisingly high estrogen activity in extracts of fo-ti not previously reported. Chaste tree berry, black cohosh, and dong quai did not have measurable activity with this method. We also discovered that removal of a glycone group from soy increases its estrogen bioactivity significantly. We conclude that this recombinant cell bioassay for estradiol can be used to measure bioactivity in herbal products. The preparations of fo-ti studied had estrogen activity of 409 +/- 55 pmol/liter estradiol equivalents per microgram of herb, which is 1/300 the activity of 17 beta-estradiol. Clinical studies are underway to determine the estrogen bioactivity in women using dietary supplements containing these herbs.


Asunto(s)
Estrógenos no Esteroides/uso terapéutico , Isoflavonas , Fitoterapia , Plantas Medicinales/química , Bioensayo , Estradiol/biosíntesis , Estrógenos/biosíntesis , Humanos , Fitoestrógenos , Preparaciones de Plantas , Receptores de Estrógenos/genética , Saccharomyces cerevisiae , Glycine max/química
10.
Int J Oral Maxillofac Surg ; 32(5): 560-2, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14759119

RESUMEN

We report a case of aspergillosis in the right temporomandibular joint (TMJ) with a history of parotid carcinoma and post-irradiation otitis. Previous treatment attempts with surgery and antibiotics were unsuccessful. Radical debridement of the glenoid fossae, supplemented with amphotericin B and adjunct hyperbaric oxygen (HBO) therapy, was provided to resolve the symptoms. This case report highlights the need to be aware of the possibility of invasive mycosis in immunocompromised patients.


Asunto(s)
Aspergilosis/microbiología , Osteorradionecrosis/microbiología , Trastornos de la Articulación Temporomandibular/microbiología , Anciano , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Aspergilosis/diagnóstico , Aspergilosis/terapia , Carcinoma de Células Escamosas/radioterapia , Humanos , Oxigenoterapia Hiperbárica , Masculino , Osteorradionecrosis/patología , Osteorradionecrosis/terapia , Neoplasias de la Parótida/radioterapia , Radioterapia/efectos adversos , Articulación Temporomandibular/microbiología , Articulación Temporomandibular/patología , Articulación Temporomandibular/cirugía , Trastornos de la Articulación Temporomandibular/diagnóstico , Trastornos de la Articulación Temporomandibular/terapia , Resultado del Tratamiento
11.
Br J Oral Maxillofac Surg ; 40(3): 213-5, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12054711

RESUMEN

We report a rare case of papillary carcinoma in the tongue and floor of the mouth with metastasis in cervical lymph nodes. Treatment was by total thyroidectomy with right radical lymph node dissection of the neck, followed by 60 Gy of radiotherapy and 100 mCi (131)I. Pathological examination of the thyroid gland showed no primary cancer. We review publications about ectopic thyroid and the value of antithyroglobulin immunostaining for diagnosis and treatment of the tumour.


Asunto(s)
Carcinoma Papilar/patología , Coristoma/patología , Suelo de la Boca/patología , Neoplasias de la Boca/patología , Glándula Tiroides/patología , Neoplasias de la Lengua/patología , Anciano , Anticuerpos , Carcinoma Papilar/secundario , Estudios de Seguimiento , Humanos , Radioisótopos de Yodo/uso terapéutico , Metástasis Linfática/patología , Masculino , Enfermedades de la Boca/patología , Disección del Cuello , Radiofármacos/uso terapéutico , Radioterapia Adyuvante , Radioterapia de Alta Energía , Tiroglobulina/análisis , Tiroidectomía , Enfermedades de la Lengua/patología
12.
J Gynecol Obstet Biol Reprod (Paris) ; 31(2 Pt 2): 1S15-1S9, 2002 Apr.
Artículo en Francés | MEDLINE | ID: mdl-11981485

RESUMEN

Clinical characteristics of PCOS Syndrome Two fundamental characteristics: hyperandrogenism and anovulation which lead to hirsutism and oligo-or amenorrhea. Other features include obesity, acanthosis nigricans, and metabolic disruption (insulin resistance with hyperinsulinemia, glucose intolerance, or type II diabetes mellitus). Complementary tests Serum testosterone and DHEA-S levels: to exclude androgen-producing tumors. Serum 17-hydroxyprogesterone level: to exclude congenital adrenal hyperplasia, 21-hydroxylase deficiency. Ultrasound: increased size of the ovaries and central stroma with presence of peripheral follicular cysts (8-10) measuring about 8 mm in diameter. Pathophysiology Therapeutic approaches Therapeutic approaches


Asunto(s)
Síndrome del Ovario Poliquístico/fisiopatología , Síndrome del Ovario Poliquístico/terapia , 17-alfa-Hidroxiprogesterona/sangre , Antagonistas de Andrógenos/uso terapéutico , Anticonceptivos Orales/uso terapéutico , Sulfato de Deshidroepiandrosterona/sangre , Diagnóstico Diferencial , Ejercicio Físico , Femenino , Humanos , Hipotálamo/fisiopatología , Ovario/diagnóstico por imagen , Ovario/fisiopatología , Hipófisis/fisiopatología , Síndrome del Ovario Poliquístico/diagnóstico , Testosterona/sangre , Ultrasonografía , Pérdida de Peso
13.
J Med Chem ; 42(23): 4764-77, 1999 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-10579840

RESUMEN

Dihydropyrimidinones such as compound 12 exhibited high binding affinity and subtype selectivity for the cloned human alpha(1a) receptor. Systematic modifications of 12 led to identification of highly potent and subtype-selective compounds such as (+)-30 and (+)-103, with high binding affinity (K(i) = 0.2 nM) for alpha(1a) receptor and greater than 1500-fold selectivity over alpha(1b) and alpha(1d) adrenoceptors. The compounds were found to be functional antagonists in human, rat, and dog prostate tissues. Compound (+)-103 exhibited excellent selectively to inhibit intraurethral pressure (IUP) as compared to lowering diastolic blood pressure (DBP) in mongrel dogs (K(b)(DBP)/K(b)(IUP) = 40) suggesting uroselectivity for alpha(1a)-selective compounds.


Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 1 , Antagonistas Adrenérgicos alfa/síntesis química , Pirimidinonas/síntesis química , Antagonistas Adrenérgicos alfa/química , Antagonistas Adrenérgicos alfa/metabolismo , Antagonistas Adrenérgicos alfa/farmacología , Animales , Unión Competitiva , Presión Sanguínea/efectos de los fármacos , Perros , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Humanos , Técnicas In Vitro , Masculino , Próstata/metabolismo , Pirimidinonas/química , Pirimidinonas/metabolismo , Pirimidinonas/farmacología , Ensayo de Unión Radioligante , Ratas , Ratas Sprague-Dawley , Receptores Adrenérgicos alfa 1/metabolismo , Estereoisomerismo , Uretra/efectos de los fármacos , Uretra/fisiología
14.
J Med Chem ; 42(23): 4778-93, 1999 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-10579841

RESUMEN

We have previously described compound 1a as a high-affinity subtype selective alpha(1a) antagonist. In vitro and in vivo evaluation of compound 1a showed its major metabolite to be a mu-opioid agonist, 4-methoxycarbonyl-4-phenylpiperidine (3). Several dihydropyrimidinone analogues were synthesized with the goal of either minimizing the formation of 3 by modification of the linker or finding alternative piperidine moieties which when cleaved as a consequence of metabolism would not give rise to mu-opioid activity. Modification of the linker gave several compounds with good alpha(1a) binding affinity (K(i) = < 1 nM) and selectivity (>300-fold over alpha(1b) and alpha(1d)). In vitro analysis in the microsomal assay revealed these modifications did not significantly affect N-dealkylation and the formation of the piperidine 3. The second approach, however, yielded several piperidine replacements for 3, which did not show significant mu-opioid activity. Several of these compounds maintained good affinity at the alpha(1a) adrenoceptor and selectivity over alpha(1b) and alpha(1d). For example, the piperidine fragments of (+)-73 and (+)-83, viz. 4-cyano-4-phenylpiperidine and 4-methyl-4-phenylpiperidine, were essentially inactive at the mu-opioid receptor (IC(50) > 30 microM vs 3 microM for 3). Compounds (+)-73 and (+)-83 were subjected to detailed in vitro and in vivo characterization. Both these compounds, in addition to their excellent selectivity (>880-fold) over alpha(1b) and alpha(1d), also showed good selectivity over several other recombinant human G-protein coupled receptors. Compounds (+)-73 and (+)-83 showed good functional potency in isolated human prostate tissues, with K(b)s comparable to their in vitro alpha(1a) binding data. In addition, compound (+)-73 also exhibited good uroselectivity (DBP K(b)/IUP K(b) > 20-fold) in the in vivo experiments in dogs, similar to 1a.


Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 1 , Antagonistas Adrenérgicos alfa/síntesis química , Piperidinas/síntesis química , Pirimidinonas/síntesis química , Antagonistas Adrenérgicos alfa/química , Antagonistas Adrenérgicos alfa/metabolismo , Antagonistas Adrenérgicos alfa/farmacología , Animales , Disponibilidad Biológica , Presión Sanguínea/efectos de los fármacos , Perros , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Proteínas de Unión al GTP/metabolismo , Semivida , Humanos , Técnicas In Vitro , Masculino , Microsomas/metabolismo , Piperidinas/química , Piperidinas/metabolismo , Piperidinas/farmacología , Próstata/metabolismo , Pirimidinonas/química , Pirimidinonas/metabolismo , Pirimidinonas/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Adrenérgicos alfa 1/metabolismo , Receptores Opioides mu/agonistas , Proteínas Recombinantes/metabolismo , Estereoisomerismo , Relación Estructura-Actividad , Uretra/efectos de los fármacos , Uretra/fisiología
15.
J Med Chem ; 42(23): 4804-13, 1999 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-10579843

RESUMEN

We have previously disclosed dihydropyridines such as 1a,b as selective alpha(1a) antagonists as a potential treatment for benign prostatic hyperplasia (BPH). The propensity of dihydropyridines toward an oxidation led us to find suitable replacements of the core unit. The accompanying papers describe the structure-activity relationship (SAR) of dihydropyrimidinones 2a,b as selective alpha(1a) antagonists. We report herein the SAR of dihydropyrimidines such as 4 and highlight the similarities and differences between the dihydropyrimidine and dihydropyrimidinone series of compounds.


Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 1 , Antagonistas Adrenérgicos alfa/síntesis química , Pirimidinas/síntesis química , Administración Oral , Antagonistas Adrenérgicos alfa/química , Antagonistas Adrenérgicos alfa/metabolismo , Antagonistas Adrenérgicos alfa/farmacología , Animales , Unión Competitiva , Disponibilidad Biológica , Perros , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Humanos , Técnicas In Vitro , Masculino , Próstata/metabolismo , Pirimidinas/química , Pirimidinas/metabolismo , Pirimidinas/farmacología , Ratas , Receptores Adrenérgicos alfa 1/metabolismo , Proteínas Recombinantes/metabolismo , Estereoisomerismo , Relación Estructura-Actividad
16.
J Med Chem ; 41(26): 5320-33, 1998 Dec 17.
Artículo en Inglés | MEDLINE | ID: mdl-9857099

RESUMEN

We report the synthesis and evaluation of novel alpha1a adrenoceptor subtype-selective antagonists. Systematic modification of the lipophilic 4,4-diphenylpiperidinyl moiety of the dihydropyridine derivatives 1 and 2 provided several highly selective and potent alpha1a antagonists. From this series, we identified the 4-(methoxycarbonyl)-4-phenylpiperidine analogue SNAP 5540 (-) [(-)-63] for further characterization. When examined in an isolated human prostate tissue assay, this compound was found to have a Ki of 2.8 nM, in agreement with the cloned human receptor binding data (Ki = 2.42 nM). Further evaluation of the compound in isolated dog prostate tissue showed a Ki of 3.6 nM and confirmed it to be a potent antagonist (Kb = 1.6 nM). In vivo, this compound effectively blocked the phenylephrine-stimulated increase in intraurethral pressure (IUP) in mongrel dogs, at doses which did not significantly affect the arterial pressure (diastolic blood pressure, DBP), with a DBP Kb/IUP Kb ratio of 16. In addition, (-)-63 also showed greater than 40 000-fold selectivity over the rat L-type calcium channel and 200-fold selectivity over several G protein-coupled receptors, including histamine and serotonin subtypes. These findings prove that alpha1a adrenoceptor-subtype selective antagonists such as (-)-63 may be developed as uroselective agents for an improved treatment of BPH over nonselective alpha1 antagonists such as prazosin and terazosin, with fewer side effects.


Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 1 , Antagonistas Adrenérgicos alfa/síntesis química , Dihidropiridinas/síntesis química , Piperidinas/síntesis química , Hiperplasia Prostática/tratamiento farmacológico , Antagonistas Adrenérgicos alfa/química , Antagonistas Adrenérgicos alfa/metabolismo , Antagonistas Adrenérgicos alfa/farmacología , Animales , Unión Competitiva , Presión Sanguínea/efectos de los fármacos , Línea Celular , Dihidropiridinas/química , Dihidropiridinas/metabolismo , Dihidropiridinas/farmacología , Perros , Evaluación Preclínica de Medicamentos , Humanos , Técnicas In Vitro , Masculino , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Músculo Liso/metabolismo , Músculo Liso/fisiología , Piperidinas/química , Piperidinas/metabolismo , Piperidinas/farmacología , Próstata/efectos de los fármacos , Próstata/metabolismo , Próstata/fisiología , Ratas , Receptores Adrenérgicos alfa 1/metabolismo , Proteínas Recombinantes/metabolismo , Estereoisomerismo , Relación Estructura-Actividad
17.
J Altern Complement Med ; 3(2): 109-18, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9395700

RESUMEN

The influence of complementary healing treatment on paraspinal electromagnetic activity at specific neuromuscular sites was examined in an exploratory pilot study that used a multisite surface electromyographic (sEMG) assessment procedure. The study was a replication and extension of previous research that indicated that complementary healing had a significant effect in normalizing the activity of the "end organ" for the central nervous system (CNS). Multisite sEMG electrodes were placed on the frontalis, cervical (C4), thoracic (T6), and lumbosacral (L3) paraspinals of 44 subjects who were divided into three groups: (1) students/patients of a Qigong practitioner (n = 16); (2) students/patients of a therapeutic touch (TT) practitioner (n = 14); and (3) nonbelievers in complementary healing (n = 14). A traditional ABAC experimental design was used with each subject evaluated for one 20-minute session that included four 5-minute segments. The purpose of this study was to measure the variable energizing effect of Qigong therapy along with the anecdotally and experimentally established relaxation effect of TT therapy relative to patient belief and expectancy. Treatment sessions consisted of Qigong and a modified form of TT intervention for all three groups. Due to the double-blind nature of the study, however, group 1 subjects were aware of only the Qigong intervention; group 2 subjects were aware of only the TT intervention, and group 3 subjects were informed that the study was designed to assess the neuromuscular activity of individuals in a seated position. The results indicated a statistically significant rise in electromagnetic activity for group 1 during the Qigong intervention segment (p < .024). Group 2 demonstrated a modest although overall nonsignificant decrease in multisite sEMG levels for both treatment protocols, whereas group 3 exhibited relatively consistent neuromuscular activity for both control and treatment segments. The results of this study are considered preliminary in nature, however, due to the potential influence of several confounds including psychophysiological factors, established behavior patterns, and the possibility for information transfer due to sensory cues.


Asunto(s)
Ejercicios Respiratorios , Electromiografía , Tacto Terapéutico , Adolescente , Adulto , Terapias Complementarias , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Método Simple Ciego
18.
Proc Soc Exp Biol Med ; 216(2): 234-45, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9349692

RESUMEN

Topical application of curcumin inhibits chemically induced carcinogenesis on mouse skin, and oral administration of curcumin inhibits chemically induced oral, forestomach, duodenal, and colon carcinogenesis. Curcumin and other inhibitors of cyclooxygenase and lipoxygenase are thought to inhibit carcinogenesis by preventing the formation of arachidonic acid metabolites. In contrast to our expectation of a tumorigenic effect of arachidonic acid, we found that treatment of 7,12-dimethylbenz[a]anthracene-initiated mouse skin with very high doses of arachidonic acid twice daily, 5 days a week for 26 weeks, failed to result in tumors. We considered the possibility that some of the cancer chemopreventive effects of curcumin may be related to an effect of this compound on cellular differentiation, and we investigated the effect of curcumin on differentiation in the human promyelocytic HL-60 leukemia cell model system. Although curcumin alone had little or no effect on cellular differentiation, when it was combined with all-trans retinoic acid or 1alpha,25-dihydroxyvitamin D3 a synergistic effect was observed. It is possible that many dietary chemicals in fruits, vegetables, and other edible plants can prevent cancer by synergizing with endogenously produced stimulators of differentiation such as all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and butyrate. More research is needed to test this hypothesis. Administration of green or black tea inhibits carcinogenesis in several animal models, and tumor growth is also inhibited. Several examples were presented of chemopreventive agents that inhibit carcinogenesis in one animal model but enhance carcinogenesis in a different animal model. Greater efforts should be made to understand mechanisms of cancer chemoprevention and to determine whether a potential chemopreventive agent is useful in many experimental settings or whether it is useful in only a limited number of experimental settings.


Asunto(s)
Anticarcinógenos , Curcumina/farmacología , Dieta , Neoplasias Experimentales/prevención & control , , Animales , Ácido Araquidónico/metabolismo , Ácido Araquidónico/farmacología , Calcitriol/uso terapéutico , Carcinógenos/farmacología , Diferenciación Celular/efectos de los fármacos , Quimioprevención , Curcumina/administración & dosificación , Curcumina/análogos & derivados , Humanos , Ratones , Neoplasias Experimentales/inducido químicamente , Neoplasias Experimentales/terapia , Té/química , Acetato de Tetradecanoilforbol/farmacología , Tretinoina/farmacología
19.
Pacing Clin Electrophysiol ; 19(7): 1082-8, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8823836

RESUMEN

This study was designed to assess the effects of isoflurane (ISO) on the electrophysiological properties of the accessory pathway, atrium, ventricle, and AV node in children with the Wolff-Parkinson-White (WPW) syndrome. The results of programmed electrical stimulation were analyzed in 51 patients (4 months to 17 years of age) with WPW. The study population was divided into two groups. Twenty-seven patients received local anesthesia and intramuscular injection of meperidine, promethazine, and chlorpromazine (MPC group). Twenty-four patients received general anesthesia with ISO inhalation (ISO group). We compared the antegrade effective refractory period of the accessory pathway (antegrade APERP), ventricular effective refractory period (VERP), atrial effective refractory period (AERP), AH interval, and cycle length of circus movement tachycardia (CMT-CL) in 12 pairs of age and sex matched patients selected from the MPC and ISO groups. Of the 12 pairs of age and sex matched patients, antegrade APERP in patients who received ISO (299 +/- 17 ms, mean +/- SEM) was significantly longer as compared with matched patients in the MPC group (262 +/- 5 ms, P < 0.025). The VERP and AERP in patients from the ISO group were significantly prolonged compared with the MPC patients (239 +/- 7 vs 210 +/- 8 ms, P < 0.025, and 228 +/- 11 vs 180 +/- 6 ms, P < 0.01, respectively). There was no significant difference in the AH interval or CMT-CL between the two subgroups. Thus, ISO prolongs the antegrade APERPs as well as the effective refractory periods of atrial and ventricular muscle in children with WPW, while the AH interval and CMT-CL appear to be unaffected. Care must be taken in interpreting measurements of the antegrade APERP made in patients under general anesthesia for RF ablation of accessory pathways.


Asunto(s)
Anestésicos por Inhalación/farmacología , Sistema de Conducción Cardíaco/efectos de los fármacos , Isoflurano/farmacología , Síndrome de Wolff-Parkinson-White/fisiopatología , Adyuvantes Anestésicos/farmacología , Anestesia por Inhalación , Anestesia Local , Estimulación Cardíaca Artificial , Estudios de Casos y Controles , Ablación por Catéter , Niño , Clorpromazina/farmacología , Femenino , Sistema de Conducción Cardíaco/fisiopatología , Humanos , Hipnóticos y Sedantes/farmacología , Masculino , Meperidina/farmacología , Prometazina/farmacología , Estudios Retrospectivos , Síndrome de Wolff-Parkinson-White/diagnóstico , Síndrome de Wolff-Parkinson-White/cirugía
20.
Carcinogenesis ; 16(10): 2493-7, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7586157

RESUMEN

Commercial grade curcumin (approximately 77% curcumin, 17% demethoxycurcumin and 3% bisdemethoxycurcumin) is widely used as a yellow coloring agent and spice in foods. In the present study topical application of commercial grade curcumin, pure curcumin or demethoxycurcumin had an equally potent inhibitory effect on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced increases in ornithine decarboxylase activity and TPA-induced tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin. Bisdemethoxycurcumin and tetrahydrocurcumin were less active. In additional studies we found that commercial grade curcumin, pure curcumin, demethoxycurcumin and bisdemethoxycurcumin had about the same potent inhibitory effect on TPA-induced inflammation of mouse ears, as well as TPA-induced transformation of cultured JB6 (P+) cells. Tetrahydrocurcumin was less active. The results indicate that pure curcumin and demethoxycurcumin (the major constituents of commercial grade curcumin) have the same potent inhibitory effects as commercial grade curcumin for inhibition of TPA-induced tumor promotion, but bisdemethoxycurcumin and tetrahydrocurcumin are less active.


Asunto(s)
Anticarcinógenos/uso terapéutico , Curcumina/análogos & derivados , Curcumina/uso terapéutico , Neoplasias Cutáneas/prevención & control , Piel/patología , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Línea Celular , Transformación Celular Neoplásica/efectos de los fármacos , Ácidos Cumáricos/uso terapéutico , Diarilheptanoides , Relación Dosis-Respuesta a Droga , Inducción Enzimática/efectos de los fármacos , Femenino , Ratones , Ratones Endogámicos , Ornitina Descarboxilasa/biosíntesis , Piel/efectos de los fármacos , Piel/enzimología , Neoplasias Cutáneas/inducido químicamente , Relación Estructura-Actividad , Acetato de Tetradecanoilforbol/toxicidad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA